Gliadin-mediated proliferation and innate immune activation in celiac disease are due to alterations in vesicular trafficking

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Barone, M Vittoria ^a   Zanzi, Delia ^a   Maglio, Mariantonia ^a   Nanayakkara, Merlin ^a   Santagata, Sara ^a   Lania, Giuliana ^a   Miele, Erasmo ^a   Ribecco, Maria Teresa Silvia ^a   Maurano, Francesco ^b   Auricchio, Renata ^a   Gianfrani, Carmen ^b   Ferrini, Silvano ^c   Troncone, Riccardo ^a   Auricchio, Salvatore ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; EPIDERMAL GROWTH FACTOR RECEPTOR; GLIADIN; GLIADIN PEPTIDE P31-43; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR ALPHA; UNCLASSIFIED DRUG; EGFR PROTEIN, HUMAN;

ARTICLE; CELIAC DISEASE; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN CACO 2; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; INNATE IMMUNITY; INTESTINE CELL; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; BIOPSY; CELL CULTURE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN TRANSPORT; TRANSPORT VESICLE;

BIOPSY; CACO-2 CELLS; CELIAC DISEASE; CELL PROLIFERATION; CELLS, CULTURED; ENTEROCYTES; GENE EXPRESSION REGULATION; GLIADIN; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-15; INTESTINAL MUCOSA; PROTEIN TRANSPORT; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSPORT VESICLES;

EID: 79952218606     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017039     Document Type: Article

References (41)

1. Sollid LM, (2000) Molecular basis of celiac disease. Annu Rev Immunol 2000;18: 53-81.
2. Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Raia V, et al. (2003) Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 362: 30-37.
3. Hue S, Mention JJ, Monteiro RC, Zhang S, Cellier C, et al. (2004) A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 21: 367-77.
4. Marsh MN, (1993) Clinical and pathological spectrum of coeliac disease. Gut 34: 1740; author reply 1.
5. Marsh MN, Crowe PT, (1995) Morphology of the mucosal lesion in gluten sensitivity. Baillieres Clin Gastroenterol 9: 273-93.
6. Marsh MN, Loft DE, Garner VG, (1992) Time dose responses of coeliac mucosae to graded oral challenges with. Frazer's Fraction III (FF3) of gliadin. Europ3′ Gastroenterol. Hepatol 4: 667-74.
7. Diosdado B, Wapenaar MC, Franke L, van Oort E, Mulder CJ, et al. (2004) A microarray screen for novel candidate genes in coeliac disease pathogenesis. Gut 53: 944-51.
8. Juuti-Uusitalo K, Maki M, Kainulainen H, Isola J, Kaukinen K, (2007) Gluten affects epithelial differentiation-associated genes in small intestinal mucosa of coeliac patients. Clin Exp Immunol 150: 294-305.
9. Barone MV, Gimigliano A, Castoria G, Maurano F, Paparo F, et al. (2007) Growth factor-like activity of gliadin, an alimentary protein: implications for coeliac disease. Gut 56: 480-8.
10. Barone MV, Nanayakkara M, Paolella G, Maglio M, Vitale V, et al. (2010) Gliadin peptide P31-43 localises to endocytic vesicles and interferes with their maturation. PloS One 18;5 (8).
11. Zimmer KP, Fischer I, Mothes T, Weissen-Plenz G, Schmitz M, et al. (2010) Endocytotic Segregation of Gliadin Peptide 31-49 in Enterocytes. Gut 59: 300-10.
12. Maiuri L, Ciacci C, Auricchio S, Ricciardelli I, Vacca L, et al. (2000) Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology 119: 996-1006.
13. Mention JJ, Ben Ahmed M, Begue B, Barbe U, Verkarre V, et al. (2003) Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 125: 730-45.
14. Harris KM, Fasano A, Mann DL, (2010) Monocytes differentiated with IL-15 support Th17 and Th1 responses to wheat gliadin: implications for celiac disease. Clin Immunol 135: 430-9.
15. Di Sabatino A, Ciccocioppo R, Cupelli F, Cinque B, Millimaggi D, et al. (2006) Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut 55: 469-77.
16. Maiuri L, Ciacci C, Vacca L, Vacca L, Raia V, et al. (2001) IL-15 drives the specific migration of CD94+ and TCR-gammadelta+ intraepithelial lymphocytes in organ cultures of treated celiac patients. Am J Gastroenterol 96: 150-6.
17. Ebert EC, (2005) IL-15 converts human intestinal intraepithelial lymphocytes to CD94 producers of IFN-gamma and IL-10, the latter promoting Fas ligand-mediated cytotoxicity. Immunology 115: 118-26.
18. Meresse B, Chen Z, Ciszewski C, Tretiakova M, Bhagat G, et al. (2004) Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21: 357-66.
19. Kinoshita N, Hiroi T, Ohta N, et al. (2002) Autocrine IL-15 mediates intestinal epithelial cell death via the activation of neighboring intraepithelial NK cells. J Immunol 169: 6187-92.
20. Fehniger TA, Caligiuri MA, (2001) Interleukin 15: biology and relevance to human disease. Blood 97: 14-32.
21. Reinecker HC, MacDermott RP, Mirau S, Dignass A, Podolsky DK, (1996) Intestinal epithelial cells both express and respond to interleukin 15. Gastroenterology 111: 1706-13.
22. Bamford RN, Battiata AP, Waldmann TA, (1996) IL-15: the role of translational regulation in their expression. J Leukoc Biol 59: 476-80.
23. Meazza R, Verdiani S, Biassoni R, Coppolecchia M, Gaggero A, et al. (1996) Identification of a novel interleukin-15 (IL-15) transcript isoform generated by alternative splicing in human small cell lung cancer cell lines. Oncogene 12: 2187-92.
24. Meazza R, Gaggero A, Neglia F, Basso S, Sforzini S, et al. (1997) Expression of two interleukin-15 mRNA isoforms in human tumors does not correlate with secretion: role of different signal peptides. Eur J Immunol 27: 1049-54.
25. Gaggero A, Azzarone B, Andrei C, Mishal Z, Meazza R, et al. (1999) Differential intracellular trafficking, secretion and endosomal localization of two IL-15 isoforms. Eur J Immunol 29: 1265-74.
26. Barzegar C, Meazza R, Pereno R, Pottin-Clemenceau C, Scudeletti M, et al. (1998) IL-15 is produced by a subset of human melanomas, and is involved in the regulation of markers of melanoma progression through juxtacrine loops. Oncogene 16: 2503-12.
27. Budagian V, Bulanova E, Paus R, Bulfone-Paus S, (2006) IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev 17: 259-80.
28. Bulfone-Paus S, Bulanova E, Budagian V, Paus R, (2006) The interleukin-15/interleukin-15 receptor system as a model for juxtacrine and reverse signaling. Bioessays 28: 362-77.
29. Dubois S, Mariner J, Waldmann TA, et al. (2002) IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells. Immunity 17: 537-47.
30. Duitman EH, Orinska Z, Bulanova E Tagaya Y, (2008) How a cytokine is chaperoned through the secretory pathway by complexing with its own receptor: lessons from interleukin-15 (IL-15)/IL-15 receptor alpha. Mol Cell Biol 28: 4851-61.
31. Huntington ND, Legrand N, Alves NL, Jaron B, Weijer K, et al. (2009) IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J Exp Med 206: 25-34.
32. Prussin C, Metcalfe DD, (1995) Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J Immunol Methods 188: 117-28.
33. Abou Elela S, Nazar RN, (1997) Role of the 5.8S rRNA in ribosome translocation. Nucleic Acids Res 25: 1788-94.
34. Barone MV, Caputo I, Ribecco MT, Maglio M, Marzari R, et al. (2007) Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease. Gastroenterology 132: 1245-53.
35. Paxton RJ, (2001) Measurement of interleukin 15. Curr Protoc Immunol Chapter 6: Unit 6 22.
36. Maxfield FR, McGraw TE, (2010) Endocytic recycling. Nat Rev Mol Cell Biol 2004;5: 121-32.
37. Scita G, Di Fiore PP, The endocytic matrix. Nature 28 (463): 464-73.
38. Yano S, Komine M, Fujimoto M, Okochi H, Tamaki K, (2003) Interleukin 15 induces the signals of epidermal proliferation through ERK and PI 3-kinase in a human epidermal keratinocyte cell line, HaCaT. Biochem Biophys Res Commun 301: 841-7.
39. Budagian V, Bulanova E, Orinska Z, Thon L, Mamat U, et al. (2005) A promiscuous liaison between IL-15 receptor and Axl receptor tyrosine kinase in cell death control. EMBO J 24: 4260-70.
40. Burgel PR, Nadel JA, (2008) Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases. Eur Respir J 32: 1068-81.
41. Bernardo D, Garrote JA, Allegretti Y, León A, Gómez E, et al. (2008) Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients. Clin Exp Immunol 154: 64-73.